Moderna patented a 19-nucleotide sequence in 2013 that matches the most infectious sequence of SARS-CoV-2

 In the quest to uncover the origins for SARS-CoV-2, scientists did not have to look far to find out that Moderna patented a 19-nucleotide sequence in 2013, that somehow, randomly appeared in the Furin cleavage site of the covid-19 spike protein

Moderna has been preparing for covid-19 mRNA vaccine experiments for years

• In the leadup to 2020, a little-known biotech company called Moderna was granted up to $100 million from the Bill and Melinda Gates Foundation to develop new vaccine candidates using mRNA technology
• From this platform, Moderna received hundreds of millions of dollars in new investments and even secured $1 billion from taxpayers in 2020

Scientists link Moderna’s patents to the most pathogenic part of SARS-CoV-2

• The 19-nucleotide sequence (patented by Moderna) randomly appeared in the furin cleavage site of the spike protein.
• If coronavirus spike protein was enhanced in a lab, then this would be the best location to enhance its pathogenic potential.

https://www.naturalnews.com/2022-10-30-moderna-patented-19-nucleotide-sequence-in-2013-matches-covid-virus.html